Resumen
El diagnóstico y tratamiento adecuados de la Enfermedad de Alzheimer deben soportarse en los datos epide- miológicos y en los costos de su impacto global. Los países en vías de desarrollo y de futuro económico incierto presentan las mayores prevalencias e incidencias de demencia.
Se presenta una revisión narrativa de estudios descriptivos, poblacionales, estadísticos, gubernamentales y de carga
o impacto económico de esta enfermedad
Citas
ROSSELLI D, ARDILA A, PRADILLA G, ET AL. The Mini-Mental State Examination as a selected diagnostic test for dementia: a Colombian population study. Rev Neurol 2000; 30: 428–32.
PRADILLA G, VESGA BE, LEON-SARMIENTO FE, ET AL. Neuroepidemiology in the eastern region of Colombia Rev Neurol 2002; 34: 1035–43.
PRADILLA G, VESGA BE, LEÓN FE Y GENECO. Estudio Neuroepidemiológico Nacional (EPI- NEURO) Colombiano. Pan Am J Puclic Health 2003; 14: 104-111.
CUSTODIO N, GUTIERREZ C, GARCIA A. Prevalencia de demencia en una comunidad urbana de Lima: un estudio puerta a puerta . Proceedings of the XII Pan-American Congress of Neurology, Santo Domingo, Dominican Republic; Oct 11–17, 2007: 17.
MOLERO AE, PINO-RAMIREZ G, MAESTRE GE. High prevalence of dementia in a Caribbean population. Neuroepidemiology 2007; 29: 107–12.
PAGES-LARRAYA FP, MARI G. Prevalence of dementia of the Alzheimer’s type, vascular demen- tia and other dementias in the city of Buenos Aires . Acta Psiquiat Psicol Am Lat 1999; 45: 122–141.
HERRERA E JR, CARAMELLI P, SILVEIRA AS, NITRINI R. Epidemiologic survey of dementia in a community-dwelling Brazilian population. Alzheimer Dis Assoc Disord 2002; 16: 103–08.
FERRI C, PRINCE M, BRAYNE M, BRODATY H, FRATIGLIONI L, GANGULI M, HALL K, HASEGAWA K, HENDRIE H, HUANG Y. Global prevalence of dementia: a Delphi consensus study The Lancet 2005; 9503: 2112-2117
http://www.dane.gov.co/files/investigaciones/ poblacion/proyepobla06_20/7Proyecciones_pobla- cion.pdf.
RUIZ DE S C, CAMARGO L, MATALLANA D, MONTAÑEZ P, ET AL. Una experiencia de 2600 val- oraciones y 1918 casos de la clínica de Memoria de la Universidad Javeriana y el Hospital Universitario de San Ignacio durante doce años (1997ª 2009). Poster Congreso Colombiano de Neurología, Acta Neurol Colomb Sept 2009; 25:170.
HELMER C, PASQUIER F, DARTIGUES JF. Epi- demiology of Alzheimer disease and related disor- ders. Medecine/Science 2006; 22:1-18.
LOBO A, LAUNER LJ, FRATIGLIONI L, ANDERSEN K, DI CARLO A, BRETELER MM ET AL. Prevalence of dementia and major subtypes in Europe: A collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group. Neurology 2000;54:4-9.
RAMAROSON H, HELMER C, BARBERGER- GATEAU P, ET AL. Prévalence de la démence et de la maladie d’Alzheimer chez les personnes de 75 ans et plus : données réactualisées de la cohorte Paquid. Rev Neurol 2003; 159: 405-11.
DE RONCHI D, BERARDI D, MENCHETTI M, ET AL. Occurrence of cognitive impairment and dementia after the age of 60: a population-based study from Northern Italy. Dement Geriatr Cogn Disord 2005; 19: 97-105.
FITZPATRICK AL, KULLER LH, IVES DG, ET AL. Incidence and prevalence of dementia in the Car- diovascular health study. J Am Geriatr Soc 2004 ; 52: 195-204.
HOFMAN A, ROCCA WA, BRAYNE C, BRE- TELER MM, CLARKE M, COOPER B ET AL. The prevalence of dementia in Europe: a collaborative study of 1980–1990 findings. Eurodem Prevalence Research Group. Int J Epidemiol 1991;20:736-48.
RITCHIE K, KILDEA D. Is senile dementia “age- related” or “ageing-related”? – evidence from meta- analysis of dementia prevalence in the oldest old. Lancet 1995;346:931-34.
FRATIGLIONI L, DE RONCHI D, AGUERO- TORRES H. Worldwide prevalence and incidence of dementia. Drugs Aging 1999;15:365-75.
MANGONE CA, ARIZAGA RL. Dementia in Argentina and other Latin- American countries: An overview. Neuroepidemiology 1999;18:231-35.
Dementia Etiology and Epidemiology The Swed- ish Council on Technology Assessment in Health Care 2008.
RATNAVALLI E, BRAYNE C, DAWSON K, HODGES J. The prevalence of frontotemporal dementia. Neurology 2002;11:1615-21.
RUIZ DE S C, CAMARGO L, MATALLANA D, MONTAÑEZ P, ET AL. Frecuencia diagnóstica y car- acterísticas de la Degeneración Frontotemporal de la Clínica de Memoria de la Universidad Javeriana y el Hospital Universitario de San Ignacio durante doce años (1997 a 2009). Poster Congreso Colombiano de Neurología, Acta Neurol Colomb 2009; 25:170.
COMAS-HERRERA, A, WITTENBERG R, PICK- ARD L, KNAPP M. Discussion Paper 2005. Cognitive impairment inolder people; its implications for future demand for services and costs; 1728.
LANGA KM, CHERNEW ME, KABETO MU, ET AL. National estimates of the quantity and cost of informal caregiving for the elderly wit dementia. J Gen intern Med 2001;16:770-78.
TAYLOR DH JR, SLOAN FA. How much do per- sons with Alzheimer´s disease cost Medicare? J AM Geriatr Soc 2000;48.639-46.
MITTELMAN MS, HALEY WE, CLAY OJ, RITH DL. Improving caregiver well-being delays nursing home placement of patients with Alzheimer disease. Neurology 2006; 67: 1592-9.
VALCOUR VG, MASAKI KH, CURB JD, BLANCHETTE PL. The detection of dementia in the primary care setting. Arch Intern Med. 2000; 160:2964-8.
BULLOCK R, DENGIZ A, Cognitive performance in patients wit Alzeimer´s disease receiving cholines- terase inhibitors for up to five years. IntJ CLin Pract 2005; 59 : 817-22.
SKOOG I, LERNFELT B, LANDAHL S, ET AL. 15-year longitudinal study of blood pressure and dementia. Lancet 1996; 347: 1141-5.
LAUNER LJ, ROSS GW, PETROVITCH H, ET AL. Midlife blood pressure and dementia: the Hono- lulu-Asia aging study. Neurobiol Aging 2000; 21: 49-55.
KIVIPELTO M, HELKALA E-L, LAASKO MP, ET AL. Midlife vascular risk factors and Alzheimer’s dis- ease in later life: longitudinal, population based study. Br Med J 2001; 322: 1447-51.
OTT A, STOLK RP, HOFMAN A, ET AL. Asso- ciation of diabetes mellitus and dementia: the Rot- terdam study. Diabetologia 1996; 39: 1392-7.
KNOPMAN D, BOLAND LL, MOSLEY T, ET AL. Cardiovascular risk factors and cognitive decline in middle-aged adults. Neurology 2001; 56: 42-8.
XU WL, QIU CX, WAHLIN A, ET AL. Diabetes mellitus and risk of dementia in the Kungsholmen project ç: a 6-year follow-up study. Neurology 2004; 63: 1181-1186.
GRAVES A, VAN DUIJN C, CHANDRA V, ET AL. Alcohol and tobacco consumption as risk factors for Alzheimer’s disease: a collaborative reanalysis of case-control studies. Eurodem risk factors research group. Int J Epidemiol 1991; 20: 48-57.
OTT A, SLOOTER AJ, HOFMAN A, ET AL. Smoking and risk of dementia and Alzheimer’s dis- ease in a population-based cohort study: the Rotter- dam Study. Lancet 1998; 351: 1840-3.
JUAN D, ZHOU DH, LI J, ET AL. A 2-year follow- up study of cigarette smoking and risk of dementia. Eur J Neurol 2004; 11: 277-82.
GUSTAFSON D, ROTHENBERG E, BLENNOW K, ET AL. An-18-year follow-up of overweight and risk of Alzheimer disease. Arch Intern Med 2003; 163: 1524-8.
DESMOND DW, MORONEY JT, SANO M, STERN
Y. Incidence of dementia after ischemic stroke: results of a longitudinal study. Stroke 2002; 33: 2254-60.
LOWERY K, BALLARD C, RODGERS H, ET AL. Cognitive decline in a prospectively studied group of stroke survivors, with a particular emphasis on the > 75’s. Age Ageing 2002; 31 (suppl 3): 24-7.
IVAN CS, SESHADRI S, BEISER A, ET AL. Dementia after stroke: the Framingham study. Stroke 2004; 35: 1264-8.
ALTIERI M, DI PIERO V, PASQUINI M, ET AL. Delayed poststroke dementia: a 4-year follow-up study. Neurology 2004; 62: 2193-7.
OTT A, BRETELER MMB, DE BRUYNE MC, ET AL. Atrial fibrillation and dementia in a pop- ulation-based study. The Rotterdam study. Stroke 1997;28 316-21.
HOFMAN A, OTT A, BRETELER MMB, ET AL. Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer’s disease in the Rotterdam study. Lancet 1997; 349: 151-4.
HOGERVORST E, RIBEIRO HM, MOLYNEUX A, ET AL. Plasma homocysteine levels, cerebrovas- cular risk factors, and cerebral white matter changes (leukoaraiosis) in patients with Alzheimer disease. Arch Neurol 2002; 59: 787-93.
WEIMER D, SAGER M. Early identification and treatment of Alzheimer´s disease: Social and fiscal outcomes. Alzhiemers Dement, 209; 5: 215-226.
BUSTANI M, CALLAHAN CM, UNVERZAGT FFW, AUSTROM MG, PERKINS AJ, FULTZ B, ET AL. Implementing a screening and diagnosis program for dementia in primary care. J Gen Intern Med
;20:572-7.
BRAYNE C, FOX C, BOUSTANI M. Dementia screening in primary care. Is it time? JAMA 2007; 298:2409-11.
Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial-SinDerivadas 4.0.